Antigens, Differentiation, Myelomonocytic
"Antigens, Differentiation, Myelomonocytic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Surface antigens expressed on myeloid cells of the granulocyte-monocyte-histiocyte series during differentiation. Analysis of their reactivity in normal and malignant myelomonocytic cells is useful in identifying and classifying human leukemias and lymphomas.
| Descriptor ID |
D015214
|
| MeSH Number(s) |
D23.050.301.264.900 D23.101.100.900
|
| Concept/Terms |
Antigens, Differentiation, Myelomonocytic- Antigens, Differentiation, Myelomonocytic
- Myelomonocytic Differentiation Antigens
- Antigens, Myelomonocytic, Differentiation
- Differentiation Antigens, Myelomonocytic
- Antigens, Myelomonocytic Differentiation
|
Below are MeSH descriptors whose meaning is more general than "Antigens, Differentiation, Myelomonocytic".
Below are MeSH descriptors whose meaning is more specific than "Antigens, Differentiation, Myelomonocytic".
This graph shows the total number of publications written about "Antigens, Differentiation, Myelomonocytic" by people in this website by year, and whether "Antigens, Differentiation, Myelomonocytic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2017 | 1 | 15 | 16 |
| 2018 | 10 | 4 | 14 |
| 2019 | 1 | 1 | 2 |
| 2020 | 1 | 2 | 3 |
| 2021 | 2 | 2 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Antigens, Differentiation, Myelomonocytic" by people in Profiles.
-
Hypopharyngeal Ulcers in COVID-19: Histopathological and Virological Analyses - A Case Report. Front Immunol. 2021; 12:676828.
-
COVID-19 myocarditis: quantitative analysis of the inflammatory infiltrate and a proposed mechanism. Cardiovasc Pathol. 2021 Sep-Oct; 54:107361.
-
Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis. Int J Mol Sci. 2021 Mar 15; 22(6).
-
An open label trial of anakinra to prevent respiratory failure in COVID-19. Elife. 2021 03 08; 10.
-
Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia. Front Immunol. 2021; 12:627548.
-
COVID-19 associated Kikuchi-Fujimoto disease. Br J Haematol. 2021 03; 192(5):e124-e126.
-
Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure. JAMA Cardiol. 2020 10 01; 5(10):1170-1175.
-
Increased Serum Levels of sCD14 and sCD163 Indicate a Preponderant Role for Monocytes in COVID-19 Immunopathology. Front Immunol. 2020; 11:560381.
-
Elevated plasma sTIM-3 levels in patients with severe COVID-19. J Allergy Clin Immunol. 2021 01; 147(1):92-98.
-
Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14. Med Hypotheses. 2020 Nov; 144:110168.